3-Bromo-2-isobutoxypyridine

Catalog No.: 
ACGWLX591
CAS No.: 
1060812-85-2
Molecular Formula: 
C9H12BrNO
Molecular Weight: 
230.10
3-Bromo-2-isobutoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$137.00InquiryInquiry
1g98%$312.00InquiryInquiry
5g98%$896.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-2-isobutoxypyridine
IUPAC Name3-bromo-2-isobutoxypyridine
MDL No.MFCD13189497
Molecular FormulaC9H12BrNO
Molecular Weight230.10
SMILESCC(C)COC1=NC=CC=C1Br
InChI KeyMOAOATMDGITQHH-UHFFFAOYSA-N
Synonym3-bromo-2-isobutoxypyridine;Pyridine, 3-bromo-2-(2-methylpropoxy)-
CAS No.1060812-85-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGWLX591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFGLZ182 route compound structure diagram
    ACFGLZ18236178-05-9In Stock
  4. Then
  5. ACGWLX591 route product structure diagram
    ACGWLX5911060812-85-2
Inquiry

2. ACGWLX591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  4. Then
  5. ACGWLX591 route product structure diagram
    ACGWLX5911060812-85-2
Inquiry

3. ACGWLX591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDETX276 route compound structure diagram
    ACDETX27613466-43-8In Stock
  4. Then
  5. ACGWLX591 route product structure diagram
    ACGWLX5911060812-85-2
Inquiry

Comments (0)